Investment firm backs Panthera Biopartners

Preston-based medical trials firm Panthera Biopartners has completed a Series A funding round with Gresham House Ventures as a major investor.

This makes funds available for Panthera to expand its network of clinical trial sites across the UK and overseas while increasing its team of clinical trial experts in serving both pharma and patients. The company is already due to open a new clinic in Glasgow.

Professor John Lyon, chairman, said: "We are delighted to have such a reputable and respected investment house as a shareholder. Despite the challenges faced with Covid, we have built Panthera into a significant player with dedicated sites across the UK in Preston, Manchester and London.

"We have also completed a breakthrough partnership agreement with Rutherford Cancer Centres, drawing patients from all over the UK through more than 170 referring oncologists."

• For further Lancashire business news, advice and analysis subscribe to Lancashire Business View or join the LBV Hub from just £2.50 per month. Click here to subscribe now.